- Home
- CERO vs EFOI Comparison
CERO vs EFOI Comparison
Compare CERO & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- EFOI
- Stock Information
- Founded
- CERO 2017
- EFOI 1985
- Country
- CERO United States
- EFOI United States
- Employees
- CERO N/A
- EFOI N/A
- Industry
- CERO
- EFOI Building Products
- Sector
- CERO
- EFOI Consumer Discretionary
- Exchange
- CERO Nasdaq
- EFOI Nasdaq
- Market Cap
- CERO 3.5M
- EFOI 12.1M
- IPO Year
- CERO N/A
- EFOI 1994
- Fundamental
- Price
- CERO $9.40
- EFOI $2.30
- Analyst Decision
- CERO Strong Buy
- EFOI
- Analyst Count
- CERO 2
- EFOI 0
- Target Price
- CERO $45.00
- EFOI N/A
- AVG Volume (30 Days)
- CERO 3.3M
- EFOI 22.4K
- Earning Date
- CERO 08-13-2025
- EFOI 08-12-2025
- Dividend Yield
- CERO N/A
- EFOI N/A
- EPS Growth
- CERO N/A
- EFOI N/A
- EPS
- CERO N/A
- EFOI N/A
- Revenue
- CERO N/A
- EFOI $4,643,000.00
- Revenue This Year
- CERO N/A
- EFOI N/A
- Revenue Next Year
- CERO N/A
- EFOI N/A
- P/E Ratio
- CERO N/A
- EFOI N/A
- Revenue Growth
- CERO N/A
- EFOI N/A
- 52 Week Low
- CERO $6.71
- EFOI $1.14
- 52 Week High
- CERO $895.40
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- CERO 47.17
- EFOI 59.77
- Support Level
- CERO $9.10
- EFOI $2.21
- Resistance Level
- CERO $9.73
- EFOI $2.37
- Average True Range (ATR)
- CERO 2.73
- EFOI 0.21
- MACD
- CERO 0.08
- EFOI 0.04
- Stochastic Oscillator
- CERO 12.57
- EFOI 78.57
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.